相似文献
1
Moving away from amyloid Beta to move on in Alzheimer research.
Front Aging Neurosci. 2015 Jan 22;7:2. doi: 10.3389/fnagi.2015.00002. eCollection 2015.
2
Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.
J Pathol. 2009 Jan;217(1):131-8. doi: 10.1002/path.2449.
3
Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
Neurochem Int. 2011 Feb;58(3):301-20. doi: 10.1016/j.neuint.2010.12.003. Epub 2010 Dec 15.
4
Alzheimer's disease.
Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24.
5
Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Brain. 2015 Jun;138(Pt 6):1722-37. doi: 10.1093/brain/awv024. Epub 2015 Mar 1.
6
Amyloid precursor protein processing and bioenergetics.
Brain Res Bull. 2017 Jul;133:71-79. doi: 10.1016/j.brainresbull.2016.08.009. Epub 2016 Aug 18.
7
The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
Antiviral Res. 2013 Sep;99(3):401-4. doi: 10.1016/j.antiviral.2013.07.003. Epub 2013 Jul 16.
8
β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1.
Biogerontology. 2015 Feb;16(1):85-98. doi: 10.1007/s10522-014-9538-8. Epub 2014 Nov 7.
9
Time to test antibacterial therapy in Alzheimer's disease.
Brain. 2019 Oct 1;142(10):2905-2929. doi: 10.1093/brain/awz244.
10
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Lancet Neurol. 2020 May;19(5):422-433. doi: 10.1016/S1474-4422(20)30071-5.
引用本文的文献
1
Brain Glucose Hypometabolism and Brain Iron Accumulation as Therapeutic Targets for Alzheimer's Disease and Other CNS Disorders.
Pharmaceuticals (Basel). 2025 Feb 19;18(2):271. doi: 10.3390/ph18020271.
2
Dietary Intake, Mediterranean and Nordic Diet Adherence in Alzheimer's Disease and Dementia: A Systematic Review.
Nutrients. 2025 Jan 17;17(2):336. doi: 10.3390/nu17020336.
3
Willingness toward post-mortem body donation to science at a Mexican university: an exploratory survey.
BMC Med Ethics. 2023 Nov 25;24(1):101. doi: 10.1186/s12910-023-00982-1.
4
A new automatic method for tracking rats in the Morris water maze.
Heliyon. 2023 Jul 15;9(7):e18367. doi: 10.1016/j.heliyon.2023.e18367. eCollection 2023 Jul.
5
Hepatic and cardiac implications of increased toxic amyloid-beta serum level in lipopolysaccharide-induced neuroinflammation in rats: new insights into alleviating therapeutic interventions.
Inflammopharmacology. 2023 Jun;31(3):1257-1277. doi: 10.1007/s10787-023-01202-3. Epub 2023 Apr 5.
6
Unbiased high-content screening reveals Aβ- and tau-independent synaptotoxic activities in human brain homogenates from Alzheimer's patients and high-pathology controls.
PLoS One. 2021 Nov 8;16(11):e0259335. doi: 10.1371/journal.pone.0259335. eCollection 2021.
7
Impact of Silibinin A on Bioenergetics in PC12APP Cells and Mitochondrial Membrane Properties in Murine Brain Mitochondria.
Antioxidants (Basel). 2021 Sep 24;10(10):1520. doi: 10.3390/antiox10101520.
8
Cardiometabolic Modification of Amyloid Beta in Alzheimer's Disease Pathology.
Front Aging Neurosci. 2021 Aug 23;13:721858. doi: 10.3389/fnagi.2021.721858. eCollection 2021.
9
On the horizon-the value and promise of the global pipeline of Alzheimer's disease therapeutics.
Alzheimers Dement (N Y). 2020 May 12;6(1):e12009. doi: 10.1002/trc2.12009. eCollection 2020.
10
Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease.
Acta Neuropathol. 2018 Nov;136(5):663-689. doi: 10.1007/s00401-018-1918-8. Epub 2018 Oct 22.
本文引用的文献
1
Improvement of neuronal bioenergetics by neurosteroids: implications for age-related neurodegenerative disorders.
Biochim Biophys Acta. 2014 Dec;1842(12 Pt A):2427-38. doi: 10.1016/j.bbadis.2014.09.013. Epub 2014 Oct 2.
2
The amyloid precursor protein controls adult hippocampal neurogenesis through GABAergic interneurons.
J Neurosci. 2014 Oct 1;34(40):13314-25. doi: 10.1523/JNEUROSCI.2848-14.2014.
3
Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease.
Acta Neuropathol Commun. 2014 Sep 18;2:135. doi: 10.1186/s40478-014-0135-5.
4
Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus.
Front Aging Neurosci. 2014 Aug 11;6:202. doi: 10.3389/fnagi.2014.00202. eCollection 2014.
5
Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
Eur J Neurol. 2015 Jan;22(1):150-5. doi: 10.1111/ene.12546. Epub 2014 Aug 21.
6
Pathogenic microbes, the microbiome, and Alzheimer's disease (AD).
Front Aging Neurosci. 2014 Jun 16;6:127. doi: 10.3389/fnagi.2014.00127. eCollection 2014.
7
HSV-1 and Alzheimer's disease: more than a hypothesis.
Front Pharmacol. 2014 May 7;5:97. doi: 10.3389/fphar.2014.00097. eCollection 2014.
8
2014 Alzheimer's disease facts and figures.
Alzheimers Dement. 2014 Mar;10(2):e47-92. doi: 10.1016/j.jalz.2014.02.001.
9
Neuropathologic correlates of trial-related instruments for Alzheimer's disease.
Am J Neurodegener Dis. 2014 Mar 28;3(1):45-9. eCollection 2014.
10
The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
Acta Neuropathol. 2013 Oct;126(4):479-97. doi: 10.1007/s00401-013-1177-7. Epub 2013 Sep 20.
Zotero 插件